ResMed
The biggest 1000 U.S. companies by revenue according to form 10-K.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
MediumRationale:
ResMed promotes divisive sex and gender policies. Its Code of Business Conduct and Ethics requires international vendors to include sexual orientation in their nondiscrimination policy (1). The company integrates ESG into its business practices, “Our mission to change the lives of 500 million people in 2030 is supported by our sustainability strategy–thoughtfully balancing the needs of all stakeholders in light of evolving global standards.” (2). However, the company has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (3).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
LowerRationale:
ResMed does not discriminate against charitable organizations based on views or beliefs (1).
Criteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
ResMed offers “Inclusive Effective Management and Inclusive Leadership” training to its employees (1). However, in 2024, the company stopped publishing its ESG Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (2). ResMed offers quarterly “Cultural Awareness” training to its employees (3). The company’s current key strategic initiatives include campaigns on: psychological safety, allyship, inclusive leadership (4). ResMed does not provide viewpoint protections for its employees (5).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
HighRationale:
ResMed releases online resources about unconscious bias (1). The company supports ESG within its business practices. It has an “integrated, impact-focused approach” to ESG (2). However, in 2024, ResMed stopped publishing its ESG Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (3). The company supports DEI within its business practices. From its Code of Business Conduct and Ethics: “As an employee of Resmed, you are faced every day with a number of business decisions. It is your personal responsibility to uphold Resmed’s high standards of business ethics, including belonging, diversity and inclusion, in each and every one of these situations.” (4). From its 2025 Sustainability Report: “We are dedicated to fostering inclusion in how we work and in the products we design, and to building diversity across all levels of our organization.” (5). From its Code of Business Conduct and Ethics: “ResMed values diversity and is inclusive toward others with different backgrounds and experiences.” (6). From its Unconscious Bias page: “We need to embrace diversity & be curious of people and things that are different to us.” (7). The company supports DEI within its business practices, employing a Diversity & Inclusion team and a Head of Diversity (8). However, in 2024, ResMed stopped publishing its ESG Report. To date, the company has not publicly addressed this change, leaving shareholders without clarity regarding the company’s reasoning or future direction (9).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
ResMed has not used corporate funds to advance ideological causes, organizations, or policies (1).